Ironwood Pharmaceuticals (irwd 1.5 06/15/26)
13F holders, Q2 2024 (June 30)3holders −1
0new positions
1sold out
$0.93avg. 13F price*
At the end of Q2 2024, 3 institutions reported holding Ironwood Pharmaceuticals (irwd 1.5 06/15/26) in their 13F filings, down 1 from Q1 2024. 0 opened new positions and 1 sold out. The largest holders were Bank of New York Mellon Corp ($187K), Cetera Investment Advisers ($34K) and Northwestern Mutual Wealth Management Co. ($6K).
- Company
- Ironwood Pharmaceuticals (irwd 1.5 06/15/26)
- CUSIP
- 46333XAH1
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $174K |
All 13F filers, Q1 2024 → Q2 2024: 18,153 shares sold, net −18,153 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Bank of New York Mellon Corp | 0.00% | No change | 200,000 | $187K |
| Cetera Investment Advisers | 0.00% | No change | 36,000 | $34K |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 6,000 | $6K |
"% of holder's portfolio" is IRONWOOD PHARMACEUTICALS (IRWD 1.5 06/15/26)'s weight in each manager's 13F, not the share of Ironwood Pharmaceuticals (irwd 1.5 06/15/26) the manager owns.